title: Stromal staining for PINCH is an independent prognostic indicator in colorectal cancer.
abstract: Particularly interesting new cysteine-histidine-rich protein (PINCH), a LIM domain adapter protein that functions in the integrin and growth factor signal transduction pathway, is upregulated in stroma associated with many common cancers. The finding suggested that PINCH may be involved in promoting tumor-stromal interactions that support tumor progression, and, if so, tumors with abundant PINCH stromal staining may have a worse prognosis. To test this hypothesis, 174 primary colorectal adenocarcinomas with 39 distant normal mucosa samples and 26 metastases in the lymph nodes were studied by immunohistochemistry, and 7 additional colon tumors were studied by Western blot analysis and immunofluorescence. The abundance of PINCH protein in stroma increased from normal mucosa to primary tumor to metastasis (P <.05), and was more intense at the invasive margin than it was in the intratumoral stroma. Strong stromal immunostaining for PINCH was shown to predict a worse outcome (rate ratio 2.1, 95% CI 1.16-3.37, P=.01), independent of Dukes stage, growth pattern, and tumor differentiation. PINCH was detected in fibroblasts, myofibroblasts, and a proportion of endothelial cells of the tumor vasculature, supporting the involvement of PINCH in promoting tumor-stromal interactions that support tumor progression. Interestingly, stromal staining for PINCH was an independent prognostic indicator in colorectal cancer.
authors.affiliation: Department of Oncology, Institute of Biomedicine and Surgery, University of Linköping, Linköping, Sweden.
authors.forename: Jingfang
authors.initials: J
authors.lastname: Gao
authors.forename: Gunnar
authors.initials: G
authors.lastname: Arbman
authors.forename: Ann
authors.initials: A
authors.lastname: Rearden
authors.forename: Xiao-Feng
authors.initials: XF
authors.lastname: Sun
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D000230:Adenocarcinoma / Q000378:metabolism* / Q000473:pathology*; D014408:Biomarkers, Tumor / Q000032:analysis; D015153:Blotting, Western; D015179:Colorectal Neoplasms / Q000378:metabolism* / Q000473:pathology*; D004268:DNA-Binding Proteins / Q000096:biosynthesis*; D005455:Fluorescent Antibody Technique; D006801:Humans; D060588:LIM Domain Proteins; D008207:Lymphatic Metastasis / Q000473:pathology; D008565:Membrane Proteins; D011379:Prognosis; D015398:Signal Transduction / Q000502:physiology; D017154:Stromal Cells / Q000378:metabolism* / Q000473:pathology
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D014408:Biomarkers, Tumor; D004268:DNA-Binding Proteins; D060588:LIM Domain Proteins; C088088:LIMS1 protein, human; D008565:Membrane Proteins
references.citation: Cancer. 2002 Sep 15;95(6):1387-95
references.pmid: 12216108
references.citation: Glia. 2003 Feb;41(3):213-23
references.pmid: 12528177
references.citation: J Surg Oncol. 1989 Dec;42(4):219-24
references.pmid: 2593664
references.citation: Biochem Biophys Res Commun. 1994 Jun 30;201(3):1124-31
references.pmid: 7517666
references.citation: J Pathol. 1997 Jul;182(3):318-24
references.pmid: 9349235
references.citation: Mol Biol Cell. 1998 Dec;9(12):3367-82
references.pmid: 9843575
references.citation: J Cell Biol. 1999 Jan 11;144(1):45-57
references.pmid: 9885243
references.citation: Mol Cell Biol. 1999 Mar;19(3):2425-34
references.pmid: 10022929
references.citation: Int J Cancer. 1999 May 17;81(4):629-36
references.pmid: 10225455